Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity
Antioxidants · 17.01.2024 · 13 (1) · 112
DOI: 10.3390/antiox13010112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 17.01.2024. Verfasst von Sibren Haesen und 15 weiteren Autor:innen. Beteiligte Einrichtung: UHasselt, Faculty of Medicine and Life Sciences, Biomedical Research Institute (BIOMED), Agoralaan, 3590 Diepenbeek, Belgium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation - Flanders, Flemish Fund for Scientific Research (FWO Flanders, Brussels, Belgium), UHasselt Special Research Fund.
Abstract (Originalsprache)
The use of doxorubicin (DOX) chemotherapy is restricted due to dose-dependent cardiotoxicity. Pyridoxamine (PM) is a vitamin B6 derivative with favorable effects on diverse cardiovascular diseases, suggesting a cardioprotective effect on DOX-induced cardiotoxicity. The cardioprotective nature of PM was investigated in a rat model of DOX-induced cardiotoxicity. Six-week-old female Sprague Dawley rats were treated intravenously with 2 mg/kg DOX or saline (CTRL) weekly for eight weeks. Two other groups received PM via the drinking water next to DOX (DOX+PM) or saline (CTRL+PM). Echocardiography, strain analysis, and hemodynamic measurements were performed to evaluate cardiac function. Fibrotic remodeling, myocardial inflammation, oxidative stress, apoptosis, and ferroptosis were evaluated by various in vitro techniques. PM significantly attenuated DOX-induced left ventricular (LV) dilated cardiomyopathy and limited TGF-β1-related LV fibrotic remodeling and macrophage-driven myocardial inflammation. PM protected against DOX-induced ferroptosis, as evidenced by restored DOX-induced disturbance of redox balance, improved cytosolic and mitochondrial iron regulation, and reduced mitochondrial damage at the gene level. In conclusion, PM attenuated the development of cardiac damage after DOX treatment by reducing myocardial fibrosis, inflammation, and mitochondrial damage and by restoring redox and iron regulation at the gene level, suggesting that PM may be a novel cardioprotective strategy for DOX-induced cardiomyopathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UHasselt, Faculty of Medicine and Life Sciences, Biomedical Research Institute (BIOMED), Agoralaan, 3590 Diepenbeek, Belgium.
- Cardiovascular Research Institute Maastricht (CARIM), School for Cardiovascular Diseases, University of Maastricht, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
- VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research (IRC) Hasselt University, 3590 Diepenbeek, Belgium.
- Department of Medical Oncology, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium.
- Department of Cardiology, Ziekenhuis Oost Limburg, Schiepse Bos 6, 3600 Genk, Belgium.
ORCID-Profile: Sibren Haesen, Lotte Vastmans, Sarah D'Haese, Ivo Lambrichts, Virginie Bito
Förderung
- Research Foundation - Flanders
- Flemish Fund for Scientific Research (FWO Flanders, Brussels, Belgium)
- UHasselt Special Research Fund
- Limburg Cancer Foundation
Zitieren
APA
Haesen, S., Jager, M. M., Brillouet, A., de Laat, I., Vastmans, L., Verghote, E., Delaet, A., D'Haese, S., Hamad, I., Kleinewietfeld, M., Mebis, J., Mullens, W., Lambrichts, I., Wolfs, E., Deluyker, D., & Bito, V. (2024). Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity. Antioxidants, 13(1), 112. https://doi.org/10.3390/antiox13010112
Vancouver
Haesen S, Jager MM, Brillouet A, de Laat I, Vastmans L, Verghote E, et al. Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity. Antioxidants. 2024;13(1):112. doi:10.3390/antiox13010112
BibTeX
@article{Haesen2024,
author = {Haesen, Sibren and Jager, Manon Marie and Brillouet, Aline and de Laat, Iris and Vastmans, Lotte and Verghote, Eline and Delaet, Anouk and D'Haese, Sarah and Hamad, Ibrahim and Kleinewietfeld, Markus and Mebis, Jeroen and Mullens, Wilfried and Lambrichts, Ivo and Wolfs, Esther and Deluyker, Dorien and Bito, Virginie},
title = {Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {1},
pages = {112},
doi = {10.3390/antiox13010112}
}
EUVIMED